Omnicell, Inc. – NASDAQ:OMCL
Omnicell stock price today
$31.95
-12.11
-27.49%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
Omnicell stock price monthly change
+65.95%
month
Omnicell stock price quarterly change
+65.95%
quarter
Omnicell stock price yearly change
+14.89%
year
Omnicell key metrics
Market Cap | 2.05B |
Enterprise value | 2.98B |
P/E | 503.42 |
EV/Sales | 2.30 |
EV/EBITDA | 30.90 |
Price/Sales | 2.08 |
Price/Book | 2.38 |
PEG ratio | -5.42 |
EPS | -0.46 |
Revenue | 1.10B |
EBITDA | 135.76M |
Income | -21.04M |
Revenue Q/Q | -15.30% |
Revenue Y/Y | -13.02% |
Profit margin | 0.44% |
Oper. margin | -0.18% |
Gross margin | 45.45% |
EBIT margin | -0.18% |
EBITDA margin | 12.31% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOmnicell stock price history
Omnicell stock forecast
Omnicell financial statements
Average Price Target
$52.67
Potential upside: 64.84%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 298.97M | 3.45M | 1.15% |
|---|---|---|---|
| Sep 2023 | 298.66M | 5.55M | 1.86% |
| Dec 2023 | 258.84M | -14.37M | -5.55% |
| Mar 2024 | 246.15M | -15.67M | -6.37% |
| 2024-05-02 | -0.08 | 0.33 |
|---|
| Jun 2023 | 2193872000 | 1.03B | 46.96% |
|---|---|---|---|
| Sep 2023 | 2221575000 | 1.03B | 46.55% |
| Dec 2023 | 2226878000 | 1.03B | 46.61% |
| Mar 2024 | 2283755000 | 1.09B | 47.95% |
| Jun 2023 | 72.90M | -14.81M | 3.60M |
|---|---|---|---|
| Sep 2023 | 57.00M | -14.18M | 2.82M |
| Dec 2023 | 38.41M | -12.37M | 13.13M |
| Mar 2024 | 49.95M | -12.34M | 11.92M |
Omnicell alternative data
| Aug 2023 | 3,830 |
|---|---|
| Sep 2023 | 3,780 |
| Oct 2023 | 3,780 |
| Nov 2023 | 3,780 |
| Dec 2023 | 3,890 |
| Jan 2024 | 3,890 |
| Feb 2024 | 3,890 |
| Mar 2024 | 3,650 |
| Apr 2024 | 3,650 |
| May 2024 | 3,650 |
| Jun 2024 | 3,590 |
| Jul 2024 | 3,590 |
Omnicell other data
61.97%
-36.64%
of OMCL is owned by hedge funds
215
-105
28.43M
-16.74M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2024 | 0 | 12000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | PARRISH MARK W director | Common Stock | 12,000 | $47.3 | $567,636 | ||
Sale | MELLON CHRISTINE MARIE officer: EVP, EXECUTIVE ADVISOR | Common Stock | 7,951 | $73.14 | $581,568 | ||
Purchase | LIPPS RANDALL A director, officer: CHAIRMAN, PR.. | Common Stock | 4,000 | $73.76 | $295,040 | ||
Option | BAUER JOANNE B director | Stock Option NQ (Right to Buy) | 19,329 | $25.53 | $493,469 | ||
Sale | BAUER JOANNE B director | Common Stock | 3,318 | $55.04 | $182,616 | ||
Sale | BAUER JOANNE B director | Common Stock | 9,797 | $53.97 | $528,715 | ||
Option | BAUER JOANNE B director | Common Stock | 19,329 | $25.53 | $493,469 | ||
Option | PARRISH MARK W director | Stock Option NQ (Right to Buy) | 3,000 | $14.87 | $44,610 | ||
Option | PARRISH MARK W director | Common Stock | 3,000 | $14.87 | $44,610 | ||
Sale | SEIDELMANN SCOTT PETER officer: EVP, CHI.. | Common Stock | 945 | $48.28 | $45,625 |
| Patent |
|---|
Application Filling date: 6 May 2022 Issue date: 18 Aug 2022 |
Grant Utility: Unit dose dispensing mechanisms Filling date: 8 Apr 2020 Issue date: 2 Aug 2022 |
Application Filling date: 24 Mar 2022 Issue date: 7 Jul 2022 |
Grant Filling date: 31 Mar 2020 Issue date: 14 Jun 2022 |
Grant Utility: IV compounding systems and methods Filling date: 30 Nov 2017 Issue date: 17 May 2022 |
Grant Filling date: 29 Jun 2020 Issue date: 10 May 2022 |
Grant Filling date: 29 Jan 2020 Issue date: 26 Apr 2022 |
Application Filling date: 17 Nov 2021 Issue date: 10 Mar 2022 |
Application Filling date: 28 Aug 2020 Issue date: 3 Mar 2022 |
Application Filling date: 28 Aug 2020 Issue date: 3 Mar 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 8 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 5 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Omnicell stock today?
One share of Omnicell stock can currently be purchased for approximately $31.95.
-
When is Omnicell's next earnings date?
Unfortunately, Omnicell's (OMCL) next earnings date is currently unknown.
-
Does Omnicell pay dividends?
No, Omnicell does not pay dividends.
-
How much money does Omnicell make?
Omnicell has a market capitalization of 2.05B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.48% to 1.15B US dollars. Omnicell made a loss 20.37M US dollars in net income (profit) last year or $0.33 on an earnings per share basis.
-
What is Omnicell's stock symbol?
Omnicell, Inc. is traded on the NASDAQ under the ticker symbol "OMCL".
-
What is Omnicell's primary industry?
Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
-
How do i buy shares of Omnicell?
Shares of Omnicell can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Omnicell have?
As Jul 2024, Omnicell employs 3,590 workers, which is 2% less then previous quarter.
-
When Omnicell went public?
Omnicell, Inc. is publicly traded company for more then 24 years since IPO on 9 Aug 2001.
-
What is Omnicell's official website?
The official website for Omnicell is omnicell.com.
-
Where are Omnicell's headquarters?
Omnicell is headquartered at 590 East Middlefield Road, Mountain View, CA.
-
How can i contact Omnicell?
Omnicell's mailing address is 590 East Middlefield Road, Mountain View, CA and company can be reached via phone at +65 02516100.
-
What is Omnicell stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for Omnicell in the last 12 months, the avarage price target is $52.67. The average price target represents a 64.84% change from the last price of $31.95.
Omnicell company profile:
Omnicell, Inc.
omnicell.comExchange:
NASDAQ
Full time employees:
3,660
Industry:
Medical - Healthcare Information Services
Sector:
Healthcare
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
590 East Middlefield Road
Mountain View, CA 94043
Mountain View, CA 94043
CIK: 0000926326
ISIN: US68213N1090
CUSIP: 68213N109
